Compugen Announces Discovery Platform to Predict Cell Penetrating Peptides for Drug Delivery
Updated: 2010-03-20 07:58:19
Home About Archives Science Bookstore Terms of Service Privacy Policy Contact Us ADVERTISMENT ADVERTISMENT Tags cell membrane novel drug peptide sequences rich infrastructure target Compugen Announces Discovery Platform to Predict Cell Penetrating Peptides for Drug Delivery Posted on 20 March 2010 07:58 by Alfie VN:F 1.8.1_1037 please wait . Rating : 0.0 5 0 votes cast Story : Summary Compugenas newly developed Intracellular Drug Delivery discovery platform enables the in silicoidentification of novel peptide sequences that are predicted to have the potential to penetrate the cell membrane . Their ability to penetrate into cells was assessed by two independent well-accepted in-vitro assay systems . In these evaluations , more than twenty of these peptides were shown to possess cell penetrating activity both by visual image analysis through confocal microscopy and quantitative measures performed by flow cytometry analysis . In addition to the substantial opportunity represented by atherapeutic cargo-carryinga , Compugen intends to integrate its Intracellular Drug Delivery discovery platform with its other in silicotherapeutic peptide discovery capabilities , such as the DAC Blockers
Most bacteria are not harmful to humans, but some can cause disease and even result in death of the host. What features make bacteria able to cause disease?
Abstract nbsp;The aim of this retrospective study was to evaluate the Immunoquick+4 (BioSynex, Strasbourg, France), a three-band malaria
rapid diagnostic test (MRDT) targeting histidine-rich protein-2 (HRP-2) and pan Plasmodium-specific parasite lactate dehydrogenase, in a non-endemic reference setting. Stored whole-blood samples (n = 613) from international travellers suspected of malaria were used, with microscopy corrected by polymerase chain reaction
(PCR) as the reference method. Samples infected by P. falciparum (n = 323), P. vivax (n = 97), P. ovale (n = 73) and P. malariae (n = 25) were selected, as well as 95 malaria-negative samples. The overall sensitivities of the Immunoquick+4 for the diagnosis
of P. falciparum, P. vivax, P. malariae and P. ovale w...
In this study, we investigated the influence of
the CFP-10/ESAT-6 complex on production of IL-12 and nitric oxide (NO) produced by the ANA-1 macrophage cell line. Preincubation
with the complex in a time-dependent manner significantly enhanced production of NO and IL-12 released from ANA-1 cells following
IFN-γ stimulation. In addition, the complex up-modulated expression level of IFN-γR1 on surface of the macrophages. Furthermore,
the effect of the complex on production of IL-12 and NO in ANA-1 cells was suppressed by AG490, a selective inhibitor of JAK/STAT
pathway. These data suggest that in the presence of IFN-γ, CFP-10/ESAT-6 complex represents a new immunogenicity and protective
factor that may be, at least partly, due to up modulation of IFN-γR1 expression and activation o...